IL11 and lung adenocarcinoma: In bronchoalveolar lavage fluid (BALF), IL-11 levels were higher in lung adenocarcinoma (median 107 pg/mL) as compared to controls, with negative detection for IL-11 solely to be ~10 to 20% in lung cancer patients depending on the cohorts [19].